« Previous
Next »
European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 1
, Pages 65-68
, November 2009
Serum C-reactive protein in the differential diagnosis of ovarian masses
References
- . Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses. Eur J Gynaecol Oncol. 2003;23(3–4):271–274
- . Significance of the tumor markers CA 125 II, CA 72-4, CASA, and CYFRA 21-1 in ovarian carcinoma. Anticancer Res. 1994;14:2743–2746
- Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer. 1999;8(5):855–859
- CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases. Br J Cancer. 1998;78(8):1108–1112
- . C-reactive protein: the best laboratory indicator available for monitoring disease activity. Cleve Clin J Med. 1989;56(2):126–130
- . C-reactive protein in atherosclerosis: a causal factor?. Cardiovasc Res. 2006;71(1):30–39
- Procalcitonin in the early phase after renal transplantation—will it add to diagnostic accuracy?. Clin Transplant. 1998;12(3):206–211
- . C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005;117:104–111
- Phylogenetic perspectives in innate immunity. Science. 1999;284:1313–1318
- . C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005;117(2):104–111
- C-reactive protein and the risk of incident colorectal cancer. JAMA. 2004;291:585–590
- Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2003;83:248–252
- The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer. 2005;103:1856–1864
- Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Urology. 2001;58:161–164
- Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1999;82:107–110
- Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Can Res. 2008;14(3):710–714
PII: S0301-2115(09)00413-8
doi: 10.1016/j.ejogrb.2009.06.010
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 1
, Pages 65-68
, November 2009
